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Synopsis 
Cycloaurated Ph3P=S and Ph3P=Se were synthesised by transmetallation reactions from 
2-Hg[(C6H4)P(E)Ph2]2 (E = S or Se) or 2-HgCl[(C6H4)P(E)Ph2]; PhP(S)(NEt2)2 was also 
cycloaurated via transmetallation reaction. 
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Graphic for synopsis 
 
 
Abstract 
The first examples of cycloaurated phosphine sulfides and triphenylphosphine selenide have 
been synthesised; these complexes are fairly rare examples of gold(III) complexes with 
potentially reducing sulfur- and selenium-donor ligands. The cycloaurated complex (2-
AuCl2C6H4)P(S)Ph2 was synthesised in good yield by transmetallation of the organomercury 
precursor 2-Hg(C6H4P(S)Ph2)2 with Me4N[AuCl4]. A route to the chloro-mercury analogue 2-
(ClHgC6H4)P(S)Ph2 was developed by reaction of the cyclomanganated triphenylphosphine 
sulfide (2-(Mn(CO)4)C6H4)P(S)Ph2 with HgCl2; this mercury substrate was also used in the 
sysnthesis of (2-AuCl2C6H4)P(S)Ph2. The cycloaurated triphenylphosphine selenide complex 
(2-AuCl2C6H4)P(Se)Ph2 was synthesised by an analogous methodology using the new 
phosphine selenide 2-Hg(C6H4P(Se)Ph2)2 [prepared from 2-Hg(C6H4PPh2)2 and elemental Se 
under sonication]. The phosphonamidic analogue (2-AuCl2C6H4)P(S)(NEt2)2 has also been 
synthesised from PhP(S)(NEt2)2 via lithiation and mercuration. X-ray crystal structures of 
several compounds are reported, and show the presence of puckered ring systems. 
 
Keywords: Gold complexes; Cyclometallated ligands; Phosphine chalcogenides; X-ray 
crystal structure; Organomercury compounds 
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Introduction 
 
 Coordination compounds of tertiary phosphine chalcogenides are well known and a 
number of reviews are dedicated to complexes with either the oxygen, sulfur or selenium 
atom of the ligand acting as a neutral η1 donor to the metal centre.1,2  Ph3P=O
3,4,5
 (a hard 
donor ligand) and Ph3P=S
3-5,
 
6
 (a soft donor ligand) both form complexes with Au(III) (a soft 
metal centre) via the electron-rich chalcogen atom. Very recently, the cycloaurated phosphine 
oxide derivative 1 was prepared by transmetallation of the corresponding methyltin 
derivatives 2.
7
 Cycloaurated complexes have been attracting considerable interest, primarily 
as a result of the redox-stabilisation of the Au(III) centre imparted by the metallacyclic 
structure.
8
 However, the majority of cycloaurated complexes involve C,N chelates, and we 
are unaware of any examples of cycloaurated phosphine-sulfides (C,S donors) or –selenides 
(C,Se donors). Complex 1 appears to be the sole example to date of a C,O cycloaurated 
system.  
 Complexes containing ortho-metallated phosphine chalcogenide ligands are themselves 
surprisingly rare in the literature. The series of ortho-manganated complexes of Ph3P=O (3a), 
Ph3P=S (3b) and Ph3P=Se (3c) has been studied;
9
 yields of the sulfide complex 3c were 
excellent (90%) but both the selenide 3c (22%) and the oxide 3a (41%) were only obtained in 
moderate yields because of either the instability of the P=Se bond or the unfavourable bond 
angle that is formed at the oxygen in the cyclometallated complex. The tin complex 4 was 
synthesised by reaction of the free ligand with Ph3SnCl via an ortho-lithiated intermediate. 
The resulting complex had weak O-Sn and S-Sn interactions both in the solid state and in 
solution. However, the cationic complex 5, formed by the reaction of 4 with CPh3
+
PF6
-
, had 
much stronger O-Sn and S-Sn interactions;
10
 stannated Ph3P=O 6 has been synthesised 
indirectly.
11
 With the exception of the Pt(II) and Pd(II) compounds (7) containing tridentate 
 4 
 
S,C,S’ pincer ligands,12 a selection of indirectly synthesised Pt(IV)13 (8 and 9) and Rh14 (10) 
compounds containing cyclometallated Ph3P=O moieties, and ortho-mercurated Ph3P=O and 
Ph3P=S,
15,16
 cyclometallated complexes of the heavier transition metal elements have thus far 
been largely neglected. 
 
Results and discussion 
 
Synthesis and characterisation of organomercury precursors 
 
 Cycloaurated complexes are typically synthesised either by direct C-H bond 
activation of the ligand by e.g. H[AuCl4], or by transmetallation, often from the 
corresponding ortho-mercurated compound.
8
 For phosphine chalcogenide ligands direct 
cyclometallation with gold was not possible, because of reduction of the gold(III), so the 
transmetallation route from the ortho-mercurated complexes was employed. Synthesis of 
ortho-mercurated complexes is commonly achieved by either direct mercuration of the 
substrate or transmetallation reactions from ortho-lithiated or Grignard intermediates, with 
the choice of method often limited by the functional groups present on the ligand.
17
 
 Bennett et al. have shown that the ortho-mercurated bisphosphine complex 11 reacts 
with either hydrogen peroxide or sulfur to yield the bisphosphine-dioxide 12a or -disulfide 
12b respectively.
15,16
 Identifying these compounds as suitable cycloauration substrates, we 
extended this series of compounds to the diselenide analogue 12c by reaction of 11 with 
(grey) selenium powder under ultrasonic conditions. The use of ultrasound allows the use of 
shorter reaction times and lower reaction temperatures than with the more traditional thermal 
route, e.g. using selenium in refluxing toluene.
18
 The selenide 12c is a white, air-stable solid 
and its 
31
P{
1
H} NMR spectrum shows a singlet at 41.4 ppm with the expected coupling to 
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both 
199
Hg (284 Hz) and 
77
Se (684 Hz). Electrospray ionisation mass spectrometry (ESI MS) 
confirmed that both phosphine groups had been converted to the corresponding selenide, 
however ions due to mixed oxide/selenide species were also present. As only one compound 
was observed in the 
31
P{
1
H} NMR spectrum it is possible that loss of selenium and 
subsequent oxidation is occurring inside the spectrometer. Alternatively, if very small traces 
of the mixed oxide/selenide species were present in the sample then they would be likely to 
have a higher proton affinity and therefore ionise more efficiently than 12c. Addition of 
AgNO3 solution to 12c prior to ESI MS analysis resulted in silver adducts in the spectrum 
(e.g. [12+Ag]
+
), however the mixed oxide/selenide species was still present. We have 
previously used silver ions to successfully derivatise (poorly-ionising) phosphine and 
phosphine chalcogenide compounds for ESI MS analysis.
19,20,21
 
 Organo-manganese reagents provide an alternative pathway to ortho-mercurated 
precursors not accessible by traditional routes.
22
 For example, reaction of ortho-manganated 
acetophenone 13 with HgCl2 yielded the ortho-mercurated derivative 14, a compound that 
cannot be formed by the classical methods of mercuration.
23
 The use of lithium or Grignard 
reagents is excluded because of the ketone functionality and direct mercuration occurs at the 
methyl carbon (as a result of keto-enol tautomerisation). Ortho-manganated Ph3P=S 3b can 
be synthesised in high yields (ca. 90%) by reaction of Ph3P=S with PhCH2Mn(CO)5
9
 so we 
investigated whether transmetallation from 3b would produce ortho-mercurated 
triphenylphosphine sulfide 15. Indeed, the desired compound is formed cleanly and in high 
yield upon refluxing 3b with a slight excess of HgCl2 in methanol (Scheme 1). The 
31
P{
1
H} 
NMR spectrum of 15 (in CDCl3) has a single peak at 48.2 ppm, which is close to the 
literature value of the bis-phosphine sulfide 12b (47.7 ppm, acquired in CD2Cl2).
16
 
 ESI MS of 15 shows ions [M+H]
+
, [M+Na]
+
 and [2M-Cl]
+
; it also indicated that the 
diarylmercury complex 12b had also been formed (by an ion at m/z 789.093 corresponding to 
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[12b+H]
+
, 100%), so an X-ray crystal structure was performed in order to unequivocally 
characterise the compound. The molecular structure and the atom labelling scheme are shown 
in Figure 1 and selected bond lengths and angles in Table 1. The mercury atom is bonded to 
the ortho carbon of one of the phenyl rings, confirming transmetallation from manganese. In 
other structurally characterised complexes where tertiary phosphine sulfides are coordinated 
to Hg(II) the S-Hg bond lengths range from 2.500 Å to 2.761 Å, and the P-S-Hg angles are in 
the range of 99.31-110.99°.
24,25
 The P-S-Hg angle in 15 (86.58°) is extremely acute; most P-
S-M angles in coordinated phosphine sulfides fall within the range of 102-116° (see Table 3). 
The P(1)-S(1) bond length in 15 [1.9745(11) Å] is longer than in Ph3P=S (1.950 Å),
26
 and the 
coordination around the mercury atom deviates slightly from linear geometry [C(12)-Hg(1)-
Cl(1) angle 173.34(9)°]. These observations indicate that the interaction between the mercury 
and sulfur [Hg(1)
...
S(1) 2.9585(8) Å] is substantial enough to hold the compound in a pseudo-
cyclic structure. 
 The ortho-mercurated thiophosphonamidic compound 16 was also prepared from 
PhP(S)(NEt2)2 and investigated as a cycloauration substrate. Craig et al.
27
 have previously 
shown that the methyl analogue PhP(S)(NMe2)2 undergoes ortho-lithiation on the phenyl 
ring; the commercially available ethyl analogue behaves in an identical manner and the 
resulting ortho-lithiated compound can be further reacted with HgCl2 to give 16 in good 
yield. Like 15, there is a peak in the mass spectrum (m/z 769.266) corresponding to the diaryl 
mercury complex [2-Hg(C6H4P(S)(NEt2)2)2+H]
+
. However, the 
31
P{
1
H} NMR spectrum 
shows a 
31
P-
199
Hg coupling of 414 Hz, very similar to the coupling seen in 15. 
Microelemental analysis also supports the structure being the mercury chloride species 16. 
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Synthesis of cycloaurated phosphine chalcogenides 
 
 The synthetic reactions are summarised in Scheme 2. The cycloaurated 
triphenylphosphine sulfide complex 17b was obtained by reaction of the ortho-mercurated 
phosphine sulfide complexes 12b and 15 with [Me4N][AuCl4] and [Me4N]Cl in acetonitrile. 
The cycloaurated triphenylphosphine selenide complex 17c was likewise formed from the 
organomercury reagent 12c. When the donor atom was selenium, the transmetallation 
reaction proceeded in three hours compared to the 24 hours required with the sulfur donor. 
Both 17b and 17c are yellow microcrystalline compounds, however 17c appears to be 
moisture sensitive and when isolated in the solid form it decomposes over time (even in 
darkness) to give a black powder. Complex 16 also readily transmetallates in an analogous 
manner; when reacted with [Me4N][AuCl4] the cycloaurated complex 18 was isolated as a 
fluffy pale-yellow solid. All of the transmetallation reactions gave adequate to good yields of 
cycloaurated product. 
 Attempts at synthesising cycloaurated Ph3P=O via transmetallation from 12a were 
unsuccessful, the same synthetic methodology as for 12b and 12c giving a variety of 
unidentified compounds observed by 
31
P{
1
H} NMR spectroscopy of the reaction mixture.  
Longer reaction times and changing the solvent from acetonitrile to DMSO resulted in 
complete loss of 12a and evidence of the cycloaurated product in ESI mass spectrometry, but, 
despite numerous attempts, we were unable to isolate 12a, which would be analogous to the 
recently reported derivative 1. 
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X-ray crystal structures of 2-AuCl2(C6H4)P(S)Ph2 17b, 2-AuCl2(C6H4)P(Se)Ph2 17c and 
2-AuCl2(C6H4)P(S)(NEt2)2 18 
 
 X-ray crystal structure analyses of 17b and 17c showed that the compounds are iso-
structural and isomorphous. The molecular structure and atom numbering scheme of the 
selenide are shown in Figure 2, with important bond parameters for both structures presented 
in Table 2; the numbering scheme for the sulfide corresponds to that of the selenide. In each 
case, a new five-membered metallacyclic ring has formed with the gold bonded in the ortho 
position of one of the phenyl rings and either a sulfur or a selenium atom as the neutral donor. 
Two chloride ligands complete the essentially square planar coordination geometry around 
the metal. The greatest deviations from the gold coordination planes are 0.0681(14) Å (C12) 
for 17b and 0.0643(8) Å (C12) for 17c. Because of the greater trans influence of the carbon-
bonded phenyl ring, the Au(1)-Cl(1) bonds in 17b and 17c [2.3635(11) and 2.3628(6) Å 
respectively] are longer than the Au(1)-Cl(2) bonds [2.3094(12) and 2.3222(6) Å] trans to the 
chalcogen. The Au-Cl bond trans to the selenium atom [2.3222(6) Å] is longer than the Au-
Cl bond trans to the sulfur atom [2.3094(12) Å] indicating a greater trans influence of the 
P=Se group. 
 Coordination to the metal lengthens the P=E bond, from 1.950(3) Å in Ph3P=S
26
 to 
2.0324(16) Å in 17b, and from 2.112(1) Å in Ph3P=Se
28
 to 2.1839(6) in 17c.  The Au-S bond 
[2.3073(11) Å] is comparable with other Au(III)-S bond lengths where the sulfur originates 
from a tertiary phosphine sulfide group.
29,30 
Likewise, the Au-Se bond in 17c is comparable 
with similar complexes
31
 and in conjunction with the P-Se bond length suggests a strong 
gold-selenium interaction. The bite angle of the ligand is close to 90° for both 17b and 17c. 
The metallacyclic rings of both complexes are significantly puckered, which contrasts to the 
ortho-manganated analogues 3b and 3c, where the metallacyclic rings are planar. The greatest 
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deviations from the mean metallacyclic plane are P(1) [+0.3002(14) Å] and S(1) [-0.3016(11) 
Å] for 17b and P(1) [+0.3114(8)] and Se(1) [-0.2976(6) Å] for 17c. 
 Table 3 summarises a review of the Cambridge Crystallographic Database for 
structures of triphenylphosphine chalcogenide ligands where the chalcogenide atom acts as an 
η1 donor.32 In these complexes the chalcogenide atom is not constrained so the intrinsically 
preferred geometry around the chalcogenide atom can be ascertained. Comparison shows that 
cycloauration imposes much more acute angles at the chalcogenide atoms (P-E-Au) in the 
gold complexes. In complexes 17b and 17c the P-E-Au angles are 95.24(5) and 91.759(18)° 
compared with unconstrained angles of 102-116° and 97-111° for Ph3PS and Ph3PSe 
complexes respectively. The P-O-Au bond angle of the cycloaurated phosphine oxide 
complex 1 is 117.0(2)°.
7
 In earlier work on ortho-manganated triphenylphosphine 
chalcogenides Depree et al. suggested that incorporation of Ph3P=O into a five-membered 
ring results in an unfavourable P-O-M bond angle at the oxygen.
9
 
 Compound 18 crystallised in the space group Pna21, with two unique molecules in 
the asymmetric unit; one of these molecules is depicted in Figure 3, clearly confirming the 
presence of the cycloaurated thiophosphorylic compound. Selected bond parameters are listed 
in Table 4. In both independent molecules the coordination around the gold atom is 
essentially square planar, with the largest deviations from the coordination plane of the metal 
being 0.0183(17) Å [C(2), molecule A] and 0.0181(11) Å [Au(1), molecule B]. As with 17b 
and 17c, the bite angle of the ligand is approximately 90°. The P-S-Au angles are 94.58(6)° 
(molecule 1) and 95.30(6)° (molecule 2) which are again severely acute and lead to the 
metallacyclic ring being extremely puckered. In both molecules it is the sulfur and 
phosphorus atoms that show the greatest deviation from the metallacyclic ring. The Au-S 
bond lengths are 2.3108(14) Å (molecule A) and 2.3064(13) Å (molecule B), which are 
comparable to the Au-S bond length in 17b (2.3073(11) Å). As expected, the Au-Cl bonds 
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trans to the carbon [2.3700(13), 2.3715(12) Å] are longer than those trans to the sulfur 
[2.3178(13), 2.3205(13) Å]. Interestingly, substituting two phenyl groups (17b) for 
diethylamino groups (18) results in an increase in Au-Cl bond lengths. The Au-Cl bond trans 
to the sulfur in 17b is 2.3094(12) Å – this increases to 2.3178(13) and 2.3205(13) Å in 18 
indicating that the amine-substituted ligand has a greater trans influence than the phenyl 
substituted ligand. 
 
Spectroscopic and mass spectrometric characterisation of cycloaurated phosphine 
chalcogenides 
 
 The presence of phosphorus in these compounds introduces a powerful (
31
P) NMR 
spectroscopic probe which aids in both characterisation of the final products and in 
monitoring reactions. In isoelectronic iminophosphorane complexes there are small changes 
in chemical shift of the compounds upon ortho-mercuration followed by a larger predictable 
downfield shift of approximately 40 ppm after transmetallation to the gold,
33,34
 attributed to 
the phosphorus entering a cyclic environment.
35
 The trend is not as obvious in the present 
chalcogenide series, with only small unpredictable changes between the ligand, ortho-
mercurated and cycloaurated complexes hence other effects must be contributing to the 
31
P 
chemical shift. Table 5 presents the 
31
P{
1
H} NMR data for the complexes studied. 
 As discussed by Glidewell et al.,
36
 the coordination of phosphine selenides to 
metal centres results in significant deshielding of the selenium nucleus and a decrease in the 
1
JPSe coupling constant – this is observed in the series of Ph3P=Se complexes. There is only a 
small change (47 Hz) upon mercuration which indicates little interaction between the 
selenium and the mercury atom. Transmetallation to gold sees a decrease in the value of 
1
JPSe  
by 259 Hz which indicates a strong selenium – gold interaction. In addition, the value of 1JPSe 
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is related to P-Se bond lengths in the solid state – the longer the P-Se bond the smaller 1JPSe 
is. This is in accordance with X-ray crystallographic data: the P-Se bond length in Ph3P=Se is 
2.112(1) Å and 
1
JPSe is 731 Hz and in the cycloaurated complex the P-Se bond length is 
2.1839(6) Å with 
1
JPSe = 425 Hz.   
 The P=E vibrations in Ph3P=S and Ph3P=Se occur at 638 cm
-1
 and 561 cm
-1
 
respectively. Upon coordination to the metal this decreases to 603 cm
-1
 for 15 and further still 
to 597 cm
-1
 for 17b. In the case of the selenide derivatives, the mercury compound 12c shows 
no change in the P=Se vibration upon mercuration, however coordination to the gold (17c) 
gives a shift to 545 cm
-1
. This further supports the inference from the NMR data that there is 
little interaction between the selenium and mercury.  Likewise, PhP(S)(NEt2)2 has a P=S 
vibration at 604 cm
-1
 which moves to lower energy for the mercury complex 16 (597 cm
-1
) 
and the cycloaurated species 18 (586 cm
-1
). These decreases mirror those seen by King and 
McQuillan, and are attributed to a weakening of the P-E π bonds upon coordination to the 
metal.
37
  
 
Reaction of (2-AuCl2C6H4)P(S)(NEt2)2, 18 with thiosalicylic acid 
 
 Because gold(III) thiosalicylate derivatives often show a greater biological activity 
than the parent dichloride complex,
38,39,40,41
 compound 18 was reacted with a molar 
equivalent of thiosalicylic acid and excess Me3N in methanol to give the thiosalicylate 
complex 19 in good yield. In previous examples of gold(III) thiosalicylate complexes the 
ligand is coordinated so that the two soft  donor ligands are mutually cis due to the anti-
symbiotic effect.
42,43
 Therefore, it is assumed that 19 is also the isomer where the carbon and 
the thiosalicylate sulfur are cis to each other. 
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 Given the interest in biological activity of gold(III) complexes, with promising 
results,
44,45,46
 some of the phosphine chalcogenide complexes reported herein have been 
subject to preliminary screening. Complex 19 shows modest activity (IC50 1522 ng mL
-1
) 
against the P388 murine leukemia cell line, while 17b shows poor activity (IC50 >12500 ng 
mL
-1
), and that of 18 is intermediate  (3474 ng mL
-1
) 
 
 
Conclusions 
Three new ortho-metallated gold(III) complexes containing phosphine chalcogenide ligands 
have been synthesised by transmetallation from organomercury substrates and fully 
characterised. These are rare examples of cycloaurated complexes which contain a neutral 
donor ligand other than nitrogen.  The complexes with the neutral sulfur donors appear to 
show similar qualitative stability to cycloaurated C,N complexes, which is interesting as they 
contain a oxidising gold(III) centre and a potentially reducing phosphine chalcogenide ligand. 
Reactivity also appears to be similar to the C,N auracycles: the cis chloride ligands can be 
replaced by the chelating dianionic thiosalicylate ligand to give a bi-metallacyclic complex 
which shows better biological activity than the parent complex against the P388 murine 
leukemia cell line. 
 
Experimental 
 
General 
General experimental procedures were as described previously.
47
 Compounds 11, 12a, 12b 
and 3b were prepared by literature procedures.
9,16
 Me4N[AuCl4] was prepared by addition of 
excess Me4NCl to an aqueous solution of H[AuCl4]. The reagents HgCl2 (BDH), PhP(NEt2)2 
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(Aldrich), selenium powder (BDH), thiosalicylic acid (Sigma), tetramethyammonium 
chloride (Aldrich) and n-butyllithium (2.0 M in cyclohexane, Aldrich) were used as received. 
 
Synthesis of 2-Hg(C6H4P(Se)Ph2)2 12c 
2-Hg(C6H4PPh2)2 11 (0.300 g, 0.42 mmol) and grey selenium powder (0.066 g, 0.84 mmol) 
were added to dry degassed toluene (50 mL) and sonicated in an ultrasonic bath at 50 °C until 
the majority of the Se had disappeared (~16 h). The toluene was removed under vacuum and 
the white solid extracted into dichloromethane (3 × 10 mL). Petroleum spirits (30 mL) was 
added to the filtrate and storage at -20 °C gave 2-Hg(C6H4P(Se)Ph2)2 12c as a white solid 
(0.225 g, 61%). Found: C 49.1, H 3.3, C36H28P2Se2Hg requires C 49.1, H 3.2%. NMR: 
1
H: δ 
7.05 (m, 4H, H-5 and H-6), 7.40 (m, 2H, H-4), 7.42 (m, 8H, H-9), 7.47 (m, 4H, H-10), 7.68 
(m, 8H, H-8), 7.78 (m, 2H, H-3); 
13
C{
1
H}: δ 125.6 (d, 3JPC 12.6 Hz, C-5), 128.6 (d, 
3
JPC 12.6 
Hz, C-9), 130.3 (d, 
4
JPC 3.6 Hz, C-4), 131.6 (d, 
4
JPC 2.4 Hz, C-10), 132.3 (d, 
2
JPC 15.8 Hz, C-
6), 132.4 (d, 
1
JPC 75.2 Hz, C-7), 133.2 (d, 
2
JPC 9.7 Hz, C-8), 140.2 (d, 
1
JPC 84.9 Hz, C-1), 
140.8 (d, 
3
JPC 19.4 Hz, C-3), 175.4 (d, 
2
JPC 25.1 Hz, C-2); 
31
P{
1
H}: δ 41.4 (3JHgP 284 Hz, 
1
JSeP 
684 Hz) ppm. ESI-MS: m/z: 904.964 (100%, [M+Na]
+
, calc 904.960), 841.040 (44%, [M-
Se+O+Na]
+
, calc 841.038), 819.064 (20%, [M-Se+O+H], calc 819.056), 882.981 (15%, 
[M+H]
+
, calc 882.978); AgNO3 added: 988.880 (100%, [M+Ag]
+
, calc 988.876), 926.957 
(25%, [M-Se+O+Ag]
+
, calc 926.954). IR: υ(P=Se) 562 (m) cm-1. 
6
5
4
3
2
1
P
Se
Hg
7
8
9
10
2
2  
 
  NMR numbering scheme for 2-Hg(C6H4P(Se)Ph2)2 12c 
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Synthesis of (2-HgClC6H4)P(S)Ph2 15 
(2-Mn(CO)4C6H4)P(S)Ph2 3b (0.406 g, 0.88 mmol) and HgCl2 (0.477 g, 1.77 mmol) were 
refluxed in methanol (15 mL) for 3 h. The white solid that formed was removed by filtration 
and the filtrate reduced in volume to give a white solid. This was subsequently re-dissolved in 
the minimum dichloromethane and passed through a column of Celite. Removal of the 
dichloromethane gave (2-HgClC6H4)P(S)Ph2 15 as a white solid (0.339 g, 73%). Found: C 
40.8, H 2.7; C18H14PSClHg requires C 40.8, H 2.7 %. NMR: 
1H:  δ 7.30 (m, 1H, H-5), 7.39 
(m, 1H, H-6), 7.47 (m, 4H, H-9), 7.55 (m, 3H, H-4 and H-10), 7.63 (m, 4H, H-8). 7.70 (m, 
1H, H-3); 
31
C{
1
H}: δ 127.5 (d, 3JPC 11.8 Hz, C-5), 129.0 (d, 
3
JPC 12.7 Hz, C-9), 131.6 (d, 
4
JPC 
3.5 Hz, C-4), 132.1 (d, 
1
JPC 86.3 Hz, C-7), 132.3 (d, 
4
JPC 3 Hz, C-10),  132.6 (d, 
2
JPC 10.6 Hz, 
C-8), 133.5 (d, 
2
JPC 13.8 Hz, C-6), 136.8 (d, 
1
JPC 89.0 Hz, C-1), 138.9 (d, 
3
JPC 17.1 Hz, C-3), 
155.8 (d, 
2
JPC 19.8 Hz, C-2); 
31
P{
1H}:  δ 48.2 (3JHgP 385 Hz) ppm. Scheme 3 gives the NMR 
numbering system. ESI-MS: m/z: 789.093 (100%, [2-Hg(C6H4P(S)Ph2)2+H]
+
, calc 789.089), 
1023.016 (20%, [2M-Cl]
+
, calc 1023.018), 552.980 (9%, [M+Na]
+
, calc 552.983). IR: υ(P=S) 
603 (m) cm
-1
. 
 
Synthesis of (2-AuCl2C6H4)P(S)Ph2 17b  
2-Hg[(C6H4)P(S)Ph2]2 12b (0.100 g, 0.13 mmol), [Me4N][AuCl4] (0.105 g, 0.26 mmol) and 
[Me4N]Cl (0.014 g, 0.13 mmol) were stirred overnight in degassed acetonitrile (15 mL) in a 
foil-covered flask. The acetonitrile was removed under vacuum and the residue extracted into 
dichloromethane (2 × 10 mL) and filtered. Slow addition of diethyl ether to the filtrate 
produced yellow crystals of (2-AuCl2C6H4)P(S)Ph2 17b (0.060 g, 42%). Found: C 38.4, H 
2.6; C18H14PSCl2Au requires C 38.5, H 2.5 %. NMR: 
1H:  δ 6.97 (m, 1H, H-6), 7.30 (m, 1H, 
H-5), 7.45 (m, 1H, H-4), 7.64 (m, 4H, H-9), 7.72 (m, 2H, H-10), 7.76 (m, 4H, H-8), 8.46 (m, 
1H, H-3); 
13
C{
1
H}: δ 125.0 (d, 1JPC 83.4 Hz, C-7), 127.9 (d, 
3
JPC 12.6 Hz, C-5), 130.2 (d, 
3
JPC 
 15 
 
13.7, C-9), 131.9 (d, 
2
JPC 14.3 Hz, C-6), 133.2 (d, 
2
JPC 11.5 Hz, C-8), 134.9 (d, 
4
JPC 3.3 Hz, 
C-4), 135.0 (d, 
4
JPC 2.7 Hz, C-10), 137.2 (d, 
3
JPC 14.8 Hz, C-3), 140.5 (d, 
1
JPC 100.0 Hz, C-1), 
152.0 (d, 
2
JPC 16.1 Hz, C-2); 
31
P{
1
H}: δ 56.4 ppm. Scheme 3 gives the NMR numbering 
system. ESI-MS: m/z: 578.999 (100%, [M-Cl+OMe+Na]
+
, calc 578.998), 1081.002 (15%, 
[2M-2Cl+OMe]
+
, calc 1080.999), 1135.010 (14%, [2M-2Cl+2OMe+Na]
+
, calc 1135.008). 
IR: υ(P=S) 597 (m) cm-1. 
 
Alternative synthesis: 
(2-HgClC6H4)P(S)Ph2 15 (0.250 g, 0.47 mmol), [Me4N][AuCl4] (0.195 g, 0.47 mmol) and 
[Me4N]Cl (0.052 g, 0.47 mmol) were stirred in degassed acetonitrile (20 mL) for 24 h in a 
foil-covered flask. The acetonitrile was removed under vacuum and the residue extracted into 
dichloromethane (2 × 10 mL) and filtered. Slow addition of diethyl ether to the filtrate 
produced yellow crystals of (2-AuCl2C6H4)P(S)Ph2 17b (0.121 g, 46%), identified by NMR 
and ESI mass spectrometry. 
 
Synthesis of (2-AuCl2C6H4)P(Se)Ph2 17c  
2-Hg[(C6H4)P(Se)Ph2]2 12c (0.100 g, 0.11 mmol), [Me4N][AuCl4] (0.094 g, 0.22 mmol) and 
[Me4N]Cl (0.012 g, 0.11 mmol) were stirred in degassed acetonitrile (10 mL) for 3 h in a foil 
covered flask. The solvent was removed under reduced pressure and the resulting yellow 
solid extracted into dichloromethane (2 × 10 mL) and filtered. The resulting filtrate was 
treated with diethyl ether (20 mL) and storage at -20 °C gave yellow crystals of 
(2-AuCl2C6H4)P(Se)Ph2 17c (0.082 g, 61%). NMR: 
1H:  δ 6.87 (m, 1H, H-6), 7.29 (m, 1H, H-
5), 7.45 (m, 1H, H-4), 7.64 (m, 4H, H-9), 7.71 (m, 2H, H-10), 7.75 (m, 4H, H-8), 8.51 (m, 
1H, H-3); 
13
C{
1H}:  δ 124.5 (d, 1JPC 75.4 Hz, C-7), 127.5 (d, 
3
JPC 13.0 Hz, C-5), 130.2 (d, 
3
JPC 13.4 Hz, C-9), 132.6 (d, 
2
JPC 13.9 Hz, C-6), 133.5 (d, 
2
JPC 11.9 Hz, C-8), 134.8 (d, 
4
JPC 
 16 
 
3.0 Hz, C-4), 134.9 (d, 
4
JPC 3.0 Hz, C-10), 138.5 (d, 
3
JPC 14.8 Hz, C-3), 140.9 (d, 
1
JPC 96.0 
Hz, C-1), 150.2 (d, 
2
JPC 19.4 Hz, C-2);  
31
P{
1H}  δ 38.8 (1JSeP 425 Hz) ppm. Scheme 3 gives 
the NMR labelling scheme. ESI-MS: m/z: 630.890 (100%, [M+Na]
+
, calc 630.893), 1238.793 
(28%, [2M+Na]
+
, calc 1238.797), 1180.838 (9%, [2M-Cl]
+
, calc 1180.838). IR:  υ(P=Se) 562 
(m) cm
-1
. 
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Scheme 3 NMR numbering scheme for 15 (M = HgCl, E = S), 17b (M = AuCl2, E = 
S) and 17c (M = AuCl2, E = Se). 
 
Synthesis of PhP(S)(NEt2)2 
PhP(NEt2)2 (2 mL, 7.9 mmol) and sulfur (0.275 g, 8.6 mmol) were stirred under nitrogen 
overnight in dry degassed hexanes (50 mL). The solvent was removed under reduced pressure 
to give a pale yellow oil that failed to crystallise (1.40 g, 62%). Found: C 59.3, H 9.1, N 9.9; 
C14H25N2PS requires C 59.1, H 8.9, N 9.9%. NMR: 
1
H: δ 1.04 (t, 12H, H-8), 3.13 (m, 8H, H-
7), 7.42 (m, 3H, H-3, H-4 and H-5), 7.93 (m, 2H, H-2 and H-6); 
13
C{
1H}:  δ 13.5 (d, 3JPC 4 
Hz, C-8), 39.4 (d,
2
JPC 4 Hz, C-7), 128.2 (d, 
3
JPC 14 Hz, C-3 and C-5), 130.9 (d, 
4
JPC 3 Hz, C-
4), 131.7 (d, 
2
JPC 10 Hz, C-2 and C-6), 135.7 (d, 
1
JPC 123 Hz, C-1); 
31
P{
1
H}: δ 78.4 ppm. 
Scheme 4 gives the NMR numbering scheme. ESI-MS: m/z: 307.138 (100%, [M+Na]
+
, calc 
307.137), 591.287 (5%, [2M+Na]
+
, calc 591.284). IR: υ(P=S) 604 cm-1. 
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Synthesis of (2-HgClC6H4)P(S)(NEt2)2 16  
PhP(S)(NEt2)2 (0.500 g, 1.76 mmol) was dissolved in dry, degassed diethyl ether (20 mL).  n-
Butyllithium (0.9 mL, 1.76 mmol) was added dropwise to give a yellow solution that was 
stirred for 22 h. HgCl2 (0.478 g, 1.76 mmol) in THF (5 mL) was added dropwise and the 
resulting grey solution stirred for a further 4 h. The grey solid that had formed was filtered 
and the filtrated evaporated under reduced pressure. The residue was redissolved in 
dichloromethane (20 mL) and refiltered. The solvent was reduced in volume (to ~ 5 mL) and 
hexanes were added until the solution went cloudy. Storage at -20 °C gave white crystals of 
(2-HgClC6H4)P(S)(NEt2)2 16 (0.503 g, 55%). Found: C 32.6, H 4.6, N 5.3; C14H24N2PSClHg 
requires C 32.4, H 4.7, N 5.4%. NMR: 
1
H: δ 1.05 (t, 12H, H-8), 3.12 (m, 8H, H-7), 7.32 (m, 
1H, H-5), 7.47 (m, 1H, H-4), 7.57 (m, 1H, H-3), 7.84 (m, 1H, H-6); 
13
C{
1
H}: δ 13.6 (d, 3JPC 
3.1 Hz, C-8), 39.9 (d, 
2
JPC 3.6 Hz, C-7), 127.1 (d, 
3
JPC 11.4 Hz, C-5), 130.8 (d, 
2
JPC 9.3 Hz, C-
6), 131.0 (d, 
4
JPC 3.4 Hz, C-4), 138.7 (d, 
3
JPC 20.5 Hz, C-3), 139.7 (d, 
1
JPC 132.1 Hz, C-1), 
156.9 (d, 
2
JPC 22.8 Hz, C-2); 
31
P{
1
H}: δ 83.1 (3JHgP 414 Hz) ppm. Scheme 4 gives the NMR 
labelling system. ESI-MS: m/z: 1003.188 (100%, [2M-Cl]
+
, calc 1003.186), 769.266 (55%, 
[2-Hg(C6H4P(S)(NEt2)2)2+H]
+
, calc 769.258), 543.071 (24%, [M+Na]
+
, calc 543.068). IR:  
υ(P=S) 597 (s) cm-1. 
 
Synthesis of (2-AuCl2C6H4)P(S)(NEt2)2 18 
(2-HgClC6H4)P(S)(NEt2)2 16 (0.150 g, 0.29 mmol), [Me4N][AuCl4] (0.119 g, 0.29 mmol) and 
[Me4N]Cl (0.032 g, 0.29 mmol) were stirred overnight in a foil-covered flask of degassed 
acetonitrile (15 mL), under a nitrogen atmosphere. The acetonitrile was removed under 
reduced pressure and the residue extracted into dichloromethane (2 × 10 mL). Hexanes (20 
mL) were added and the solution stored at -20 °C to give fluffy yellow crystals of 
(2-AuCl2C6H4)P(S)(NEt2)2 18 (0.106 g, 66%). Found: C 30.0, H 4.5, N 4.9; 
 18 
 
C14H24N2PSCl2Au requires 30.5, H 4.4, N 5.1%. NMR: 
1H:  δ 1.20 (t, 12H, H-8), 3.25 (m, 
8H, H-7), 7.11 (m, 1H, H-6), 7.30 (m, 1H, H-5), 7.40 (m, 1H, H-4), 8.39 (m, 1H, H-3);  
13
C{
1
H}: δ 13.9 (3JPC 2.5 Hz, C-8), 40.7 (
2
JPC 4.7 Hz, C-7), 127.4 (
3
JPC 13.1 Hz, C-5), 129.9 
(
2
JPC 11.5 Hz, C-6), 134.7 (
4
JPC 2.9 Hz, C-4), 135.8 (
1
JPC 139.0 Hz, C-1), 136.2 (
3
JPC 17.3 Hz, 
C-3), 144.0 (
2
JPC 24.6 Hz, C-2); 
31
P{
1
H}: δ 79.4 ppm. Scheme 4 gives the NMR labelling 
system. ESI-MS: m/z: 1067.114 (100%, [2M-Cl]
+
, calc 1067.116), 573.033 (95%, [M+Na]
+
, 
calc 573.033), 1061.166 (73%, [2M-2Cl+OMe]
+
, 1061.168), 1125.072 (58%, [2M+Na]
+
, calc 
1125.075), 515.074 (38%, [M-Cl]
+
, calc 515.075). IR:  υ(P=S) 586 (m) cm-1. 
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Scheme 4 NMR numbering scheme for (Et2N)2P(S)Ph (M=H), 16 (M=HgCl) and 18 
(M=AuCl2). 
 
 
Reaction of (2-AuCl2C6H4)P(S)(NEt2)2 18 with thiosalicylic acid 
(2-AuCl2C6H4)P(S)(NEt2)2 18 (0.051 g, 0.09 mmol) and thiosalicylic acid (0.014 g, 0.09 
mmol) were stirred in methanol (10 mL). To the dark orange solution Me3N (1 mL, excess) 
was added resulting in the solution becoming immediately lighter. The solution was stirred 
for 90 min. in a foil covered flask before water (50 mL) was added to produce a fine 
precipitate. Stirring was continued for a further 12 h, the solution was filtered and the yellow 
solid washed with water (2 × 10 mL) and diethyl ether (1 × 10 mL). Drying under vacuum 
gave 0.043 g (76%) of the thiosalicylate derivative 19. Found: C 39.9, H 4.5, N 4.5, 
C21H28N2O2PS2Au requires C 39.9, H 4.5, N 4.4%. NMR: 
1
H: δ 1.14 (t, 12H, H-8), 3.25 (m, 
 19 
 
8H, H-7), 7.12 (m, 1H, H-6), 7.18 (m, 2H, H-11 and H-12), 7.27 (m, 1H, H-5), 7.39 (m, 2H, 
H-4 and H-10), 7.93 (m, 1H, H-3), 8.16 (m, 1H, H-13); 
13
C{
1
H}: δ 13.7 (3JPC 2.8 Hz, C-8), 
40.4 (
2
JPC 4.5 Hz, C-7), 125.4 (C-12), 127.0 (
3
JPC 13.0 Hz, C-5), 129.9 (C-10 and C-11), 
130.4 (
2
JPC 10.8 Hz, C-6), 133.2 (C-13), 134.0 (
4
JPC 3.3 Hz, C-4), 134.1 (C-14), 134.2 (
3
JPC 
16.1 Hz, C-3), 134.7 (
2
JPC 21.5 Hz, C-2), 136.8 (C-9), 141.6 (
1
JPC 138.0 Hz, C-1), 168.6 (C-
15); 
31
P{
1
H}: δ 75.0 ppm. ESI-MS: m/z: 633.109 (100%, [M+H]+, calc 633.107), 655.092 
(64%, [M+Na]
+
, calc 655.089), 763.254 (27%, [2-Au(C6H4P(S)(NEt2)2)2]
+
, calc 763.247), 
1287.192 (21%, [2M+Na]
+
, calc 1287.188), 1265.210 (6%, [2M+H]
+
, calc 1265.206). IR: 
υ(P=S) 587 (m); υ(C=O) 1624 (vs) cm-1. 
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Antitumour assays 
Assays to determine the in vitro anti-tumour activity against the P388 Murine Leukemia cell 
line were carried out by Gill Ellis of the Marine Chemistry Group at the University of 
Canterbury. The sample was dissolved in the solvent and incubated with P388 murine 
leukemia cells for 72 h. IC50 values were determined using absorbance values obtained when 
the dye MMT tetrazolium (yellow) was reduced to MMT formazan (purple). 
 
X-ray crystal structure determinations of 15, 17b, 17c and 18 
 In all cases single crystals suitable for X-ray diffraction were grown by vapour 
diffusion of diethyl ether into a dichloromethane solution of the compound at room 
 20 
 
temperature. Unit cell and intensity data were collected at the University of Auckland on a 
Bruker Smart CCD Diffractometer, operating at 89 K; crystallographic details are presented 
in Table 6.  Absorption corrections were applied by semi-empirical methods (SADABS
48
). 
 The structures of 15 and 18 were solved by the direct methods option of SHELXS-
97, 17b and 17c by the Patterson methods option.
49
 In all cases the heavy metal was initially 
located and all other non-hydrogen atoms by a series of difference maps. Hydrogen atoms 
were placed in calculated positions. Refinement was with SHELXL-97.
50
 
 An initial inspection of 18 indicated that the two independent molecules in Pna21 
were possibly related by an inversion centre. A closer examination showed that the heavy 
atoms (Au, P, N, S and Cl) were related by approximate symmetry but the lighter atoms were 
not. Attempts to solve and refine the structure in the centrosymmetric space group Pnma were 
not successful, confirming Pna21. Refinement suggested racemic twinning with 0.76:0.24 
occupancy so this was included in the final model. 
 
Supplementary material 
 Crystallographic data (excluding structure factors) for the structures described in this 
paper have been deposited with the Cambridge Crystallographic Data Centre, CCDC Nos. 
(743531) 15, (743530) 17b, (743528) 17c and (743529) 18. Copies of the data can be 
obtained free of charge on application to The Director, CCDC, 12 Union Road, Cambridge 
CB2 1EZ, UK (Fax: +44-1223-336033; e-mail deposit@ccdc.cam.ac.uk or www:  
http://www.ccdc.cam.ac.uk). 
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Table 1 Selected structural parameters for the complex (2-HgClC6H4)P(S)Ph2 15 
 
Atoms Lengths (Å)  Atoms Angles (°) 
P(1) – S(1) 1.9745(11) S(1) – P(1) – C(11) 114.51(11) 
P(1) – C(11) 1.824(3) P(1) - C(11) – C(12) 121.3(2) 
C(11) – C(12) 1.400(4) C(11) – C(12) – Hg(1) 121.7(2) 
C(12) – Hg(1) 2.068(3) C(12) – Hg(1) – Cl(1) 173.34(9) 
Hg(1) – Cl(1) 2.3273(8) C(11) – P(1) – C(31) 106.25(14) 
S(1)---Hg(1) 2.9585(8) C(21) – P(1) – C(11) 105.86(14) 
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Table 2 Selected structural parameters for the complexes 17b and 17c 
 
 17b (E=S) 17c (E=Se) 
Bond lengths (Å) 
  
Au(1) – Cl(1) 2.3635(11) 2.3628(6) 
Au(1) – Cl(2) 2.3094(12) 2.3222(6) 
C(12) – Au(1) 2.045(5) 2.049(2) 
E(1) – Au(1) 2.3073(11) 2.4091(3) 
P(1) – E(1) 2.0324(16) 2.1839(6) 
P(1) – C(11) 1.794(4) 1.783(2) 
C(11) – C(12) 1.401(6) 1.406(3) 
   
Bond angles (°)   
Cl(1) – Au(1) – Cl(2) 90.64(4) 90.52(2) 
Cl(1) – Au(1) – E(1) 86.25(4) 84.876(18) 
E(1) – Au(1) – C(12) 90.02(13) 91.16(7) 
C(12) – Au(1) – Cl(2) 93.23(13) 93.60(7) 
Au(1) – E(1) – P(1) 95.24(5) 91.759(18) 
E(1) – P(1) – C(11) 104.57(15) 104.17(8) 
C(11) – C(12) – Au(1) 120.2(3) 120.99(18) 
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Table 3 Results of a search of the Cambridge Crystallographic Database¶  
for η1 coordinated Ph3P=E ligands 
 
 
 Ph3P=O Ph3P=S Ph3P=Se 
Sample number 357 19 11 
Independent XPPh3 moieties 636 24 13 
Mean P-E-M angle (°) 158.2 109.1 104.0 
Std deviation in P-E-M angle (°) 5.7 3.0 4.5 
Range P-E-M angle (°) 125-180 102-116 97-111 
P-E-Au angle (°) * 95.24 (17b) 91.759 (17c) 
 
 
 
¶ Version 5.30, May 2009 release. Only those hits with R1 ≤ 0.075 were included 
 
* P-O-Au angle 117.0(2)° in complex 1 
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Table 4 Selected structural parameters for the complex (2-
AuCl2C6H4)P(S)(NEt2)2 18 
 
 Molecule A Molecule B 
Bond lengths (Å) 
  
Au(1) – Cl(1) 2.3700(13) 2.3715(12) 
Au(1) – Cl(2) 2.3178(13) 2.3205(13) 
Au(1) – S(1) 2.3108(14) 2.3064(13) 
Au(1) – C(2) 2.059(5) 2.051(5) 
P(1) – S(1) 2.0403(19) 2.0451(18) 
P(1) – C(1) 1.781(5) 1.776(5) 
C(1) – C(2) 1.398(7) 1.414(7) 
P(1) – N(1) 1.628(5) 1.638(5) 
P(1) – N(2) 1.623(4) 1.619(4) 
   
Bond angles (°)   
Cl(1) – Au(1) – Cl(2) 91.49(5) 90.28(5) 
Cl(2) – Au(1) – C(2) 93.21(15) 92.90(15) 
Cl(1) – Au(1) – S(1) 85.88(5) 86.43(5) 
C(2) – Au(1) – S(1) 89.42(14) 90.37(15) 
Au(1) – S(1) – P(1) 94.58(6) 95.30(6) 
S(1) – P(1) – C(1) 102.91(17) 102.68(17) 
P(1) – C(1) – C(2) 116.2(4) 117.1(4) 
C(1) – C(2) – Au(1) 119.3(4) 118.6(4) 
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Table 5 31P{1H} NMR chemical shifts (ppm) of the metallated phosphine 
chalcogenide ligands used in this study (CDCl3) 
 
 
 
 Ligand Ortho-mercurated 
complex 
Cycloaurated complex 
Ph3P=S 44.0  48.2 (
3
JP-Hg = 385 Hz) 56.4  
 
Ph3P=Se 36.0 (
1
JP-Se = 731 Hz) 41.4 (
1
JP-Se = 684 Hz) 38.8 (
1
JP-Se = 425 Hz) 
    (
3
JP-Hg = 284 Hz) 
 
  
PhP(S)(NEt2)2 78.4  83.1 (
3
JP-Hg = 414 Hz) 79.4  
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Table 6 Crystal and refinement data for the complexes 15, 17b, 17c and 18 
 
Complex 15 17b 17c 18 
Formula C18H14PSClHg C18H14PSCl2Au C18H14PCl2SeAu C14H24N2PSCl2Au 
Molecular mass 529.36 561.19 608.09 551.25 
T/K 89 89 89 89 
Crystal system Monoclinic Triclinic Triclinic Orthorhombic 
Space group P21/c P-1 P-1 Pna21 
a (Å) 8.8845(1) 8.1875(1) 8.1506(1) 27.3998(9) 
b (Å) 17.2034(1) 9.1443(1) 9.2374(1) 7.9520(3) 
c (Å) 11.2712(2) 12.4011(1) 12.4369(2) 17.1925(6) 
α (°) 90 98.705(1) 80.142(1) 90 
β (°) 101.8490(1) 102.795(1) 76.934(1) 90 
γ (°) 90 90.484(1) 89.994(1) 90 
V (Å
3
) 1686.02(4) 894.124(16) 897.94(2) 3746.0(2) 
Z 4 2 2 8 
Dcalc (g cm
-3
) 2.085 2.084 2.249 1.955 
Tmax,min 0.2524, 0.1026 0.2742, 0.2285 0.4170, 0.1553 0.2397, 0.2038 
Number of unique reflections 3430 3657 4284 7379 
Number of observed reflections [I>2σ(I)] 3258 3562 4147 6979 
R[I>2σ(I)] 0.0200 0.0274 0.0152 0.0216 
wR2 (all data) 0.0525 0.0717 0.0360 0.0457 
Goodness of Fit 1.060 1.106 1.073 1.130 
Flack x parameter    0.2364(4)
* 
 
*
 Racemic twin (occupancy 0.76/0.24) 
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Figure 1 Structure of the complex (2-HgClC6H4)P(S)Ph2 15 showing the atom 
numbering scheme. Thermal ellipsoids are shown at the 50% probability 
level. 
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Figure 2 Molecular diagram of (2-AuCl2C6H4)P(Se)Ph2 17c indicating the atom 
numbering scheme, with thermal ellipsoids at the 50% probability level. 
The cycloaurated phosphine sulfide 17b is isostructural, and has a 
comparable numbering scheme. 
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Figure 3 Molecular structure of (2-AuCl2C6H4)P(S)(NEt2)2 18 showing one of the 
unique molecules in the asymmetric unit. Hydrogen atoms have been 
excluded for clarity and thermal ellipsoids are shown at the 50% probability 
level. 
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